Ning Y, Zhou X, Wang G, Zhang L, Wang J
Curr Diabetes Rev. 2024; 21(2):e070524229720.
PMID: 38712372
DOI: 10.2174/0115733998297749240418071555.
Mandal N, Grambergs R, Mondal K, Basu S, Tahia F, Dagogo-Jack S
J Diabetes Complications. 2020; 35(2):107734.
PMID: 33268241
PMC: 8663915.
DOI: 10.1016/j.jdiacomp.2020.107734.
Shayman J
Semin Nephrol. 2018; 38(2):183-192.
PMID: 29602400
PMC: 6317906.
DOI: 10.1016/j.semnephrol.2018.01.007.
Harrison-Bernard L
Am J Physiol Renal Physiol. 2015; 309(8):F685-6.
PMID: 26155845
PMC: 4609915.
DOI: 10.1152/ajprenal.00287.2015.
Merscher S, Fornoni A
Front Endocrinol (Lausanne). 2014; 5:127.
PMID: 25126087
PMC: 4115628.
DOI: 10.3389/fendo.2014.00127.
A structure-guided mutation in the major capsid protein retargets BK polyomavirus.
Neu U, Allen S, Blaum B, Liu Y, Frank M, Palma A
PLoS Pathog. 2013; 9(10):e1003688.
PMID: 24130487
PMC: 3795024.
DOI: 10.1371/journal.ppat.1003688.
Renal distribution of ganglioside GM3 in rat models of types 1 and 2 diabetes.
Novak A, Rezic Muzinic N, culic V, Bozic J, Kurir T, Ferhatovic L
J Physiol Biochem. 2013; 69(4):727-35.
PMID: 23564406
DOI: 10.1007/s13105-013-0249-4.
Shiga toxin pathogenesis: kidney complications and renal failure.
Obrig T, Karpman D
Curr Top Microbiol Immunol. 2011; 357:105-36.
PMID: 21983749
PMC: 3779650.
DOI: 10.1007/82_2011_172.
Ganglioside GM3 levels are altered in a mouse model of HIBM: GM3 as a cellular marker of the disease.
Paccalet T, Coulombe Z, Tremblay J
PLoS One. 2010; 5(4):e10055.
PMID: 20383336
PMC: 2850932.
DOI: 10.1371/journal.pone.0010055.
Use of Bodipy-labeled sphingolipid and cholesterol analogs to examine membrane microdomains in cells.
Marks D, Bittman R, Pagano R
Histochem Cell Biol. 2008; 130(5):819-32.
PMID: 18820942
PMC: 3922293.
DOI: 10.1007/s00418-008-0509-5.
Sulfatide and Na+-K+-ATPase: a salinity-sensitive relationship in the gill basolateral membrane of rainbow trout.
Lingwood D, Fisher L, Callahan J, Ballantyne J
J Membr Biol. 2005; 201(2):77-84.
PMID: 15630545
DOI: 10.1007/s00232-004-0708-3.
rMAL is a glycosphingolipid-associated protein of myelin and apical membranes of epithelial cells in kidney and stomach.
Frank M, van der Haar M, Schaeren-Wiemers N, Schwab M
J Neurosci. 1998; 18(13):4901-13.
PMID: 9634556
PMC: 6792556.
Polycystic kidney disease: an unrecognized emerging infectious disease?.
Hjelle J, Jones M, Mayberry W, Dombrink-Kurtzman M, Peterson S, Nowak D
Emerg Infect Dis. 1997; 3(2):113-27.
PMID: 9204292
PMC: 2627604.
DOI: 10.3201/eid0302.970204.
Sphingolipid activator proteins in a human hereditary renal disease with deposition of disialogangliosides.
Haltia A, Solin M, Jalanko H, Holmberg C, Miettinen A, Holthofer H
Histochem J. 1996; 28(10):681-7.
PMID: 8950597
DOI: 10.1007/BF02409005.
Decrease of glomerular disialogangliosides in puromycin nephrosis of the rat.
Holthofer H, Reivinen J, Solin M, Haltia A, Miettinen A
Am J Pathol. 1996; 149(3):1009-15.
PMID: 8780404
PMC: 1865163.
Sorting of newly synthesized galactosphingolipids to the two surface domains of epithelial cells.
Van der Bijl P, Lopes-Cardozo M, van Meer G
J Cell Biol. 1996; 132(5):813-21.
PMID: 8603914
PMC: 2120744.
DOI: 10.1083/jcb.132.5.813.
A role for glycosphingolipid accumulation in the renal hypertrophy of streptozotocin-induced diabetes mellitus.
Zador I, Deshmukh G, Kunkel R, Johnson K, RADIN N, Shayman J
J Clin Invest. 1993; 91(3):797-803.
PMID: 8450061
PMC: 288030.
DOI: 10.1172/JCI116299.
Dexamethasone modulates rat renal brush border membrane phosphate transporter mRNA and protein abundance and glycosphingolipid composition.
Levi M, Shayman J, Abe A, Gross S, McCluer R, Biber J
J Clin Invest. 1995; 96(1):207-16.
PMID: 7615789
PMC: 185190.
DOI: 10.1172/JCI118022.
Biogenesis of myeloid bodies in regenerating newt (Notophthalmus viridescens) retinal pigment epithelium.
Abran D, Dickson D
Cell Tissue Res. 1992; 268(3):531-8.
PMID: 1628309
DOI: 10.1007/BF00319160.
